Overall, the “Hidradenitis Suppuritiva Update 2026” session underscored a new treatment paradigm: HS care in 2026 requires early diagnosis, systemic screening, combination medical therapy, and ...
Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and ...
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies ...
The exact cause of hidradenitis suppurativa is unclear, but it is likely due to a combination of genetic factors, immune system dysfunction, and clogged hair follicles. Smoking and obesity can ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce hidradenitis suppurativa severity, flares, and pain, especially in obese patients. Improvements were observed in Hidradenitis ...
In a pooled analysis of 25 studies from 23 countries, a two-question screening tool demonstrated excellent diagnostic ...
Please provide your email address to receive an email when new articles are posted on . Diagnosing hidradenitis suppurativa requires consideration of the signs and symptoms of disease as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results